Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13107 | 796 | 30.2 | 75% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1619 | 6500 | ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IMMUNODEFICIENCY ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS | Author keyword | 4 | 75% | 0% | 3 |
2 | RADIATION THERAPY COMPLICATIONS | Author keyword | 2 | 67% | 0% | 2 |
3 | STANDARDIZED INCIDENCE RATE | Author keyword | 2 | 67% | 0% | 2 |
4 | AGE RISK | Author keyword | 1 | 50% | 0% | 2 |
5 | CERVICAL HUMAN PAPILLOMAVIRUS INFECTION | Author keyword | 1 | 50% | 0% | 2 |
6 | FAMILY COMMUNITY MED STOCKHOLM | Address | 1 | 50% | 0% | 2 |
7 | IMMUNE DISTURBANCE | Author keyword | 1 | 33% | 0% | 2 |
8 | ACTIVATED FIBROBLAST | Author keyword | 1 | 50% | 0% | 1 |
9 | ALLERGY CLIN EPIDEMIOL | Address | 1 | 50% | 0% | 1 |
10 | ANTI TUMOR NECROSIS FACTOR TNF AGENTS | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REVERSIBLE LYMPHOMAS | 8 | 60% | 1% | 9 |
2 | LYMPHOMA RISK | 4 | 35% | 1% | 9 |
3 | FAMILIAL RISKS | 3 | 24% | 1% | 11 |
4 | COLLAGEN VASCULAR DISEASES | 2 | 12% | 2% | 14 |
5 | CANCER MORBIDITY | 1 | 20% | 1% | 4 |
6 | EXCESS RISK | 1 | 13% | 1% | 5 |
7 | RARE ASSOCIATION | 1 | 16% | 1% | 4 |
8 | COMMON COMPLEX DISEASES | 1 | 50% | 0% | 1 |
9 | ESTIMATING RISKS | 1 | 50% | 0% | 1 |
10 | HIP REPLACEMENT PATIENTS | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Methotrexate-associated lymphoproliferative disorders of the tongue developing in patients with rheumatoid arthritis: a report of 2 cases and a review | 2015 | 1 | 16 | 69% |
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature | 2014 | 10 | 33 | 64% |
The risk of lymphoma development in autoimmune diseases - A meta-analysis | 2005 | 255 | 53 | 45% |
Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review | 2011 | 21 | 30 | 73% |
Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature | 2009 | 30 | 32 | 81% |
A systematic review of the incidence and prevalence of cancer in multiple sclerosis | 2015 | 1 | 37 | 30% |
Lupus and cancer | 2009 | 35 | 66 | 68% |
Epstein-Barr Virus-Positive Oral Ulceration Simulating Hodgkin Lymphoma in a Patient Treated With Methotrexate: Case Report and Review of the Literature | 2014 | 3 | 15 | 87% |
Systemic lupus and malignancies | 2012 | 9 | 32 | 84% |
Multiple Associations Between a Broad Spectrum of Autoimmune Diseases, Chronic Inflammatory Diseases and Cancer | 2012 | 44 | 127 | 24% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FAMILY COMMUNITY MED STOCKHOLM | 1 | 50% | 0.3% | 2 |
2 | ALLERGY CLIN EPIDEMIOL | 1 | 50% | 0.1% | 1 |
3 | AUTOIMMUNE MUSCULOSKELETAL | 1 | 50% | 0.1% | 1 |
4 | CANADIAN ARTHRIT NETWORK | 1 | 50% | 0.1% | 1 |
5 | CLIN CONNECT TISSUE DIS | 1 | 50% | 0.1% | 1 |
6 | EPIDEMIOL REGISTRE CANC | 1 | 50% | 0.1% | 1 |
7 | EPIDEMOL BIOSTAT | 1 | 50% | 0.1% | 1 |
8 | HGR 45 | 1 | 50% | 0.1% | 1 |
9 | IE3M | 1 | 50% | 0.1% | 1 |
10 | INVEST BIOMED BIOPATOL MED REGENERAT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000178935 | CHROMOSOME 5 ABNORMALITY//PHARM NTHC NARILIS//UNIDAD HEMATOL CLIN |
2 | 0.0000167490 | PARANEOPLASTIC VASCULITIS//PALMAR FASCIITIS//LEUKEMIC ARTHRITIS |
3 | 0.0000135761 | DS DNA ANTIBODIES//INTERNAL AUTOIMMUNE METAB DIS//CHU PITIE SALPETRIERE HP |
4 | 0.0000106278 | SLAM ASSOCIATED PROTEIN SAP//ANTI CMV ANTIBODIES//VARICELLA ARTHRITIS |
5 | 0.0000100818 | NON HODGKIN//ENVIRONM EPIDEMIOL CANC GRP//EPIDEMIOL GENET UNIT |
6 | 0.0000074264 | METHOTREXATE//METHOTREXATE POLYGLUTAMATES//MX 68 |
7 | 0.0000070841 | ABATACEPT//TOCILIZUMAB//DISEASE MODIFYING ANTIRHEUMATIC DRUGS |
8 | 0.0000069283 | SARCOID LIKE REACTION//SARCOID REACTION//SARCOIDOSIS LYMPHOMA SYNDROME |
9 | 0.0000062892 | SHIITAKE DERMATITIS//FLAGELLATE DERMATITIS//FLAGELLATE ERYTHEMA |
10 | 0.0000061255 | DRUG INDUCED LUPUS//DRUG INDUCED LUPUS ERYTHEMATOSUS//TNF ALPHA ANTAGONISTS |